Polymorphisms in multiple genes are associated with resting heart rate in a stepwise allele-dependent manner

Heart Rhythm

Volumn 5, Issue 5, 2008, Pages 694-700

  Wilton, Stephen B ^a   Anderson, Todd J ^a   Parboosingh, Jillian ^a   Bridge, Peter J ^a   Exner, Derek V ^a   Forrest, Dana ^a   Duff, Henry J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Beta 1 adrenergic receptor; Calsequestrin; Cardiac sodium channel; Cohort study; Heart rate; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALSEQUESTRIN; CALSEQUESTRIN 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SODIUM CHANNEL;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; ELECTROCARDIOGRAM; FEMALE; FIRE FIGHTER; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HEART AUTOMATICITY; HEART RATE; HUMAN; HYPERTENSION; INTRON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REST; SINGLE NUCLEOTIDE POLYMORPHISM; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; TACHYCARDIA; UNIVARIATE ANALYSIS;

ADULT; ALLELES; COHORT STUDIES; GENOTYPE; HEART RATE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 42649120098     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.01.039     Document Type: Article

References (35)

1. Dyer A.R., Persky V., Stamler J., et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112 (1980) 736-749
2. Filipovsky J., Ducimetiere P., and Safar M.E. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 20 (1992) 333-339
3. Gillum R.F., Makuc D.M., and Feldman J.J. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 121 (1991) 172-177
4. Greenland P., Daviglus M.L., Dyer A.R., et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 149 (1999) 853-862
5. Kannel W.B., Kannel C., Paffenbarger Jr. R.S., et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113 (1987) 1489-1494
6. Kristal-Boneh E., Silber H., Harari G., et al. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 21 (2000) 116-124
7. Engel G., Cho S., Ghayoumi A., et al. Prognostic significance of PVCs and resting heart rate. Ann Noninvas Electrocardiol 12 (2007) 121-129
8. Jouven X., Empana J.-P., Schwartz P.J., et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352 (2005) 1951-1958
9. Fox K., Borer J.S., Camm A.J., et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50 (2007) 823-830
10. Janssen I., Katzmarzyk P.T., Church T.S., et al. The Cooper Clinic Mortality Risk Index: clinical score sheet for men. Am J Prev Med 29 (2005) 194-203
11. Berne R., and Levy M. Cardiovascular physiology. eds: 8 (2001), Mosby, St Louis 85-114
12. Kreutz R., Struk B., Stock P., et al. Evidence for primary genetic determination of heart rate regulation: chromosomal mapping of a genetic locus in the rat. Circulation 96 (1997) 1078-1081
13. Martin L.J., Comuzzie A.G., Sonnenberg G.E., et al. Major quantitative trait locus for resting heart rate maps to a region on chromosome 4. Hypertension 43 (2004) 1146-1151
14. Singh J.P., Larson M.G., O'Donnell C.J., et al. Heritability of heart rate variability: the Framingham Heart Study. Circulation 99 (1999) 2251-2254
15. Bengtsson K., Melander O., Orho-Melander M., et al. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 104 (2001) 187-190
16. Ranade K., Jorgenson E., Sheu W.H., et al. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70 (2002) 935-942
17. Liu J., Liu Z.Q., Tan Z.R., et al. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 74 (2003) 372-379
18. Buscher R., Belger H., Eilmes K.J., et al. In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics 11 (2001) 199-205
19. O'Shaughnessy K.M., Fu B., Dickerson C., et al. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) 99 (2000) 233-238
20. Xie H.G., Dishy V., Sofowora G., et al. Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 11 (2001) 191-197
21. Anderson T.J., Roberts A.C., Hildebrand K., et al. The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study. Can J Cardiol 19 (2003) 61-66
22. Cuzick J. A Wilcoxon-type test for trend. Stat Med 4 (1985) 87-90
23. Mason D.A., Moore J.D., Green S.A., et al. A gain-of-function polymorphism in a G-protein coupling domain of the human beta 1-adrenergic receptor. J Biol Chem 274 (1999) 12670-12674
24. Liggett S.B., Mialet-Perez J., Thaneemit-Chen S., et al. A polymorphism within a conserved beta1-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. PNAS 103 (2006) 11288-11293
25. Benson D.W., Wang D.W., Dyment M., et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 112 (2003) 1019-1028
26. McNair W.P., Ku L., Taylor M.R., et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110 (2004) 2163-2167
27. Smits J.P., Koopmann T.T., Wilders R., et al. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol 38 (2005) 969-981
28. Lei M., Goddard C., Liu J., et al. Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a. J Physiol 567 (2005) 387-400
29. Makielski J.C., Ye B., Valdivia C.R., et al. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res 93 (2003) 821-828
30. Viswanathan P.C., Benson D.W., and Balser J.R. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest 111 (2003) 341-346
31. Vinogradova T.M., Maltsev V.A., Bogdanov K.Y., et al. Rhythmic Ca2+ oscillations drive sinoatrial nodal cell pacemaker function to make the heart tick. Ann N Y Acad Sci 1047 (2005) 138-156
32. Knollmann B.C., Chopra N., Hlaing T., et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 116 (2006) 2510-2520
33. Das S.K., Chu W., Zhang Z., et al. Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians. Diabetes 53 (2004) 3300-3306
34. Pfeufer A., Jalilzadeh S., Perz S., et al. Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res 96 (2005) 693-701
35. Ter Keurs H.E., and Boyden P.A. Calcium and arrhythmogenesis. Physiol Rev 87 (2007) 457-506